Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-05

Clinical Trial Update: Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing the bioavailability of Vagantin-coated tablets with a methantheline bromide solution in neurogenic bladder; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methantheline bromide (methantheline bromide)
  • Vagantin®

Snippet

Sponsor: University Medicine Greifswald | Conditions: Neurogenic Bladder | Phase 1 | Status: COMPLETED